Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 20, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnstone Biologics Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Fulcrum Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 27
| |||||||
Fulcrum Therapeutics, Inc.
| -6.77K |
$15.00 | -$101,490.00 | -1.34% | 499.86K |
Jan 13
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 27
| |||||||
Fulcrum Therapeutics, Inc.
|
0
|
$7.97 | -$17,844.46 |
—
| 506.63K |
Jun 7
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
|
0
|
$7.92 | -$10,493.46 |
—
| 506.63K |
Jun 2 - Jun 6
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
|
0
|
$15.93 | -$91,081.42 |
—
| 506.63K |
Apr 7
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
|
0
|
$16.00 | -$1,537,755.87 |
—
| 506.63K |
Apr 1 - Apr 5
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
| -10.00K |
$12.16 | -$121,578.33 | -1.94% | 506.63K |
Mar 15 - Mar 16
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
| -8.21K |
$14.27 | -$117,197.40 | -1.57% | 516.63K |
Feb 16
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 2
| |||||||
Fulcrum Therapeutics, Inc.
| -10.00K |
$12.08 | -$120,826.00 | -1.87% | 524.85K |
Jan 20
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
| -2.50K |
$20.00 | -$50,000.00 | -0.47% | 534.85K |
Jul 8
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
| -2.50K |
$20.80 | -$51,992.00 | -0.46% | 537.35K |
Jun 25
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
| -156.00 |
$20.00 | -$3,120.00 | -0.03% | 539.85K |
Jun 9
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
| -3.43K |
$20.17 | -$69,251.16 | -0.63% | 540K |
Jun 5
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
| -2.80K |
$20.09 | -$56,250.43 | -0.51% | 543.43K |
Jun 3 - Jun 4
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
| -2.80K |
$20.00 | -$56,040.00 | -0.51% | 546.23K |
Jun 1 - Jun 2
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
| -3.31K |
$20.04 | -$66,301.91 | -0.60% | 549.04K |
May 28 - May 29
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
| -2.50K |
$20.00 | -$50,000.00 | -0.45% | 552.35K |
May 26
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
| -2.50K |
$20.00 | -$50,000.00 | -0.45% | 554.85K |
Feb 19
|
Scheduled
| ||||||
Fulcrum Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 23
| |||||||
Fulcrum Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 18
| |||||||
Fulcrum Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Epizyme, Inc.
|
0
|
$9.26 | -$561,956.49 |
—
|
0
|
Dec 29 - Dec 30
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
$10.19 | -$1,161,142.28 |
—
|
0
|
Sep 8
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
$11.24 | -$1,287,754.02 |
—
|
0
|
Aug 3
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
$11.87 | -$1,362,480.08 |
—
|
0
|
Jul 6
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 13
| |||||||
Epizyme, Inc.
|
0
|
$12.73 | -$733,323.37 |
—
|
0
|
Nov 3
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
$13.40 | -$773,000.30 |
—
|
0
|
Oct 1
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
$16.99 | -$988,600.58 |
—
|
0
|
Sep 2
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
$15.38 | -$891,956.24 |
—
|
0
|
Aug 1
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
$16.02 | -$930,495.36 |
—
|
0
|
Jul 1
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
$11.36 | -$650,760.24 |
—
|
0
|
Jun 2
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
$11.21 | -$642,137.77 |
—
|
0
|
May 1
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
$10.37 | -$591,438.00 |
—
|
0
|
Apr 7
|
Scheduled
| ||||||
Epizyme, Inc.
|
0
|
$14.88 | -$1,724,400.00 |
—
|
0
|
Feb 10
| |||||||
Epizyme, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 28
| |||||||
Epizyme, Inc.
|
0
|
$10.25 | -$594,654.27 |
—
|
0
|
Jan 2
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.